Guanzhong Wu - Concepedia

Author

Guanzhong Wu

China Pharmaceutical University

Also Known As

Guan-zhong Wu, Guanzhong Wu

Publications

905

Citations

H-Index

Concepts

All Affiliations

China Pharmaceutical University

About

Guanzhong Wu is an author at China Pharmaceutical University specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	346
2	Biochemistry	5	5	292
3	Natural Sciences	3	3	247
4	Health Sciences	2	2	113
5	Public Health	1	1	80

Guanzhong Wu

Publications

465

Citations

H-Index

Page 1

	Year	Citations
Pentacyclic triterpenes. Part 1: The first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases Xiaoan Wen, Hongbin Sun, Jun Liu, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryGlycogen PhosphorylasesMedicineNatural Sciences	2005	112
Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase Jun Chen, Jun Liu, Luyong Zhang, Bioorganic & Medicinal Chemistry Letters BiosynthesisBioorganic ChemistryGlycosylationBiochemistryNatural Sciences	2006	96
Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet Yongqi Guo, Guanzhong Wu, Xin Su, Nutrition Research ObesityMetabolic SyndromeNutritionLipid NutritionPhysiology	2009	80
Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway Qian Yu, Minda Zhang, Lifen Qian, Life Sciences InflammationNlrp3 Inflammasome PathwayAnti-inflammatorySignal TransductionCell Signaling	2019	80
Synthesis and biological evaluation of sulfonylurea and thiourea derivatives substituted with benzenesulfonamide groups as potential hypoglycemic agents Huibin Zhang, Ya-an Zhang, Guanzhong Wu, Bioorganic & Medicinal Chemistry Letters Pharmaceutical ScienceThiourea DerivativesBioorganic ChemistryDerivative (Chemistry)Biochemistry	2009	39
Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice Ying Wang, Yumeng Wan, Guihong Ye, European Journal of Pharmaceutical Sciences Metabolic SyndromeHepatologyBiochemistryMedicineLiver Physiology	2016	33
G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE −/− mice Lifen Qian, Lingman Ma, Guanzhong Wu, Vascular Pharmacology InflammationAnti-inflammatoryAnti-atherosclerosis EffectsMedicineImmunology	2017	13
I4, a new synthetic sulfonylurea compound, inhibits the action of TXA2 in vivo and in vitro on platelets and aorta vascular smooth muscle Na Lu, Minxia Zhan, Cong Gao, Thrombosis Research ThrombosisMolecular PharmacologyBiochemistryBlood PlateletMedicine	2012	12

Page 1